Anez C. Ebrahim

Array ( [id] => 3475309 [patent_doc_number] => 05428024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'High concentration homogenized collagen compositions' [patent_app_type] => 1 [patent_app_number] => 8/229859 [patent_app_country] => US [patent_app_date] => 1994-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5125 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428024.pdf [firstpage_image] =>[orig_patent_app_number] => 229859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700897 [patent_doc_number] => 05646113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Treatment of partial growth hormone insensitivity syndrome' [patent_app_type] => 1 [patent_app_number] => 8/224982 [patent_app_country] => US [patent_app_date] => 1994-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 13710 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646113.pdf [firstpage_image] =>[orig_patent_app_number] => 224982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695304 [patent_doc_number] => 05618790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Protease mediated drug delivery system' [patent_app_type] => 1 [patent_app_number] => 8/213897 [patent_app_country] => US [patent_app_date] => 1994-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5101 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618790.pdf [firstpage_image] =>[orig_patent_app_number] => 213897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3613304 [patent_doc_number] => 05534493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Use of growth factor IGF-I or IGF-II' [patent_app_type] => 1 [patent_app_number] => 8/193017 [patent_app_country] => US [patent_app_date] => 1994-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2757 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534493.pdf [firstpage_image] =>[orig_patent_app_number] => 193017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3565597 [patent_doc_number] => 05482926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Growth factor IGF-Il' [patent_app_type] => 1 [patent_app_number] => 8/190168 [patent_app_country] => US [patent_app_date] => 1994-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2452 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482926.pdf [firstpage_image] =>[orig_patent_app_number] => 190168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724213 [patent_doc_number] => 05681817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Treatment of ovarian estrogen dependent conditions' [patent_app_type] => 1 [patent_app_number] => 8/191631 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4562 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681817.pdf [firstpage_image] =>[orig_patent_app_number] => 191631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3034819 [patent_doc_number] => 05376368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-27 [patent_title] => 'Composition and method for treating inflammation' [patent_app_type] => 1 [patent_app_number] => 8/186762 [patent_app_country] => US [patent_app_date] => 1994-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3848 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/376/05376368.pdf [firstpage_image] =>[orig_patent_app_number] => 186762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3491537 [patent_doc_number] => 05470948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Vasopressin and vasotocin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/078289 [patent_app_country] => US [patent_app_date] => 1993-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5630 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470948.pdf [firstpage_image] =>[orig_patent_app_number] => 078289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3482698 [patent_doc_number] => 05446024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-29 [patent_title] => 'Purification of insulin-like growth factor' [patent_app_type] => 1 [patent_app_number] => 8/169688 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 33 [patent_no_of_words] => 20679 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/446/05446024.pdf [firstpage_image] =>[orig_patent_app_number] => 169688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598611 [patent_doc_number] => 05559096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Pharmaceutical compositions against gastric disorders' [patent_app_type] => 1 [patent_app_number] => 8/129134 [patent_app_country] => US [patent_app_date] => 1993-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2666 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559096.pdf [firstpage_image] =>[orig_patent_app_number] => 129134 [rel_patent_id] =>[rel_patent_doc_number] =>)